Effectiveness of drug, abhayadi ghrita and vishagna lepa on patients affected with eczema.

Role of abhayadi ghrita and vishaghna lepa in the clinical management of dushivisha janya pama W.S.R. to eczema.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/043424

Enrollment

Registered

2022-06-22

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: All patients presenting symptoms of dushivisha janya pama will be included for clinical trial.

Exclusion criteria

Exclusion criteria: Patients below 18 years and above 60 years of age, patient of burn, severe allergic disease, leprosy, herpes, carcinoma, HIV, terminal illnesses, pregnant women, lactating mother.

Design outcomes

Primary

Measure	Time frame
Reduction of symptoms of dushivisha janya pama 1)Kandu 2)Sraav 3)Daah 4)Pidika 5)Vaivarnya Timepoint: First follow up after 15 days	—

Secondary

Measure	Time frame
Reduction in symptoms 1.kandu 2.sraav 3.daah 4.pidika 5.vaivarnyaTimepoint: 60 days	—

Countries

India

Contacts

Public ContactDr Yuvraj Kaushik

Shri n.p.a govt. Ayurved college, raipur, c.g.

sinchulkar@yahoo.co.in9425215318

Outcome results